Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphoid × Imatinib Mesylate × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Burkitt Lymphoma 2 Uveal Melanoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Neoplasms 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Melanoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Biphenotypic, Acute 1 Gastrointestinal Stromal Tumors 1 Desmoid Tumors 1 Dermatofibrosarcoma 1 Chordoma 1 Carcinoma, Adenoid Cystic 1 Blast Crisis 1

Interventions

fludarabine 2 Whole-Body Irradiation 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Cyclophosphamide 2 Busulfan 2 pirtobrutinib 1 ibrutinib 1 fludarabine phosphate 1 Thiotepa 1 Sirolimus 1 Patient Reported Outcome Measures 1 Mycophenolic Acid 1 Methotrexate 1 Mesna 1 Melphalan 1 Cyclosporins 1 Cyclosporine 1 Bone Marrow Transplantation 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡